Transfusion-associated circulatory overload: A survey among Dutch intensive care fellows;Surcharge circulatoire post-transfusionnelle: un sondage entre les internes réanimation néerlandais

Transfusion Clinique et Biologique

Volumn 25, Issue 1, 2018, Pages 19-25

  Klanderman, R B ^a   Attaye, I ^a   Bosboom, J J ^a   Veelo, D P ^a   Geerts, B F ^a   Vlaar, A P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ICU; Infusion rate; Survey; TACO; Transfusion

Indexed keywords

FRESH FROZEN PLASMA; FUROSEMIDE; GLYCERYL TRINITRATE;

AGED; ARTICLE; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH SURVEY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFUSION; INFUSION RATE; INFUSION VOLUME; INTENSIVE CARE UNIT; LUNG COMPLICATION; MALE; PRACTICE GUIDELINE; RISK FACTOR; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; ATTITUDE TO HEALTH; BLOOD SAFETY; BLOOD TRANSFUSION; CLINICAL COMPETENCE; INTENSIVE CARE; LEGISLATION AND JURISPRUDENCE; MEDICAL EDUCATION; MEDICAL STAFF; MEDICINE; NETHERLANDS; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RISK MANAGEMENT;

BLOOD SAFETY; BLOOD TRANSFUSION; CLINICAL COMPETENCE; CRITICAL CARE; EDUCATION, MEDICAL, CONTINUING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; MEDICINE; NETHERLANDS; RISK FACTORS; RISK MANAGEMENT; SURVEYS AND QUESTIONNAIRES; TRANSFUSION REACTION;

EID: 85044851448     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2017.11.001     Document Type: Article

References (26)

1. Rapport d'activité hémovigilance 2015. 2015, Agence Nationale de Sécurite du Médicamente et des produits de santé (ANSM), France [Accessed June 6, 2017, at http://ansm.sante.fr/var/ansm_site/storage/original/application/27ce3d0739821882c0cd87041b8050a7.pdf].
2. Annual SHOT Report 2015., 2015, Serious Hazards of Transfusion (SHOT), United Kingdom [Accessed September 26, 2017, at http://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked-1.pdf].
3. TRIP Rapport 2015 – Hemovigilantie Uitgebreide Versie. 2015, Transfusie- en Transplantatiereacties in Patiënten (TRIP), The Netherlands [Accessed June 26, 2017, at https://www.tripnet.nl/pages/nl/documents/TRIP2014Hemovigilantie.pdf].
4. Fatalities reported to FDA following blood collection and transfusion. 2015, Food and Drug Administration (FDA), United States of America [Accessed June 26, 2017, at http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf].
5. Proposed standard definitions for surveillance of non-infectious adverse transfusion reactions. 2011, International Society of Blood Transfusion – Working party on haemovigilance [Accessed on September 23, 2016, at http://www.ihn-org.com/wp-content/uploads/2011/06/ISBT-definitions-for-non-infectious-transfusion-reactions.pdf].
6. Roubinian, N.H., Hendrickson, J.E., Triulzi, D.J., Gottschall, J.L., Chowdhury, D., Kor, D.J., et al. Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm. Vox Sang 112 (2017), 56–63.
7. Li, G., Rachmale, S., Kojicic, M., Shahjehan, K., Malinchoc, M., Kor, D.J., et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 51 (2011), 338–343.
8. Bierbaum, B.E., Callaghan, J.J., Galante, J.O., Rubash, H.E., Tooms, R.E., Welch, R.B., An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999), 2–10.
9. Raval, J.S., Mazepa, M.A., Russell, S.L., Immel, C.C., Whinna, H.C., Park, Y.A., Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang 108 (2015), 387–392.
10. Clifford, L., Singh, A., Wilson, G.A., Toy, P., Gajic, O., Malinchoc, M., et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 53 (2013), 1205–1216.
11. Narick, C., Triulzi, D.J., Yazer, M.H., Transfusion-associated circulatory overload after plasma transfusion. Transfusion 52 (2012), 160–165.
12. Shehata, N., Forster, A.J., Lawrence, N., Ducharme, R., Fergusson, D.A., Chasse, M., et al. Transfusion patterns in all patients admitted to the intensive care unit and in those who die in hospital: a descriptive analysis. PLoS One, 10, 2015, e0138427.
13. Murphy, E.L., Kwaan, N., Looney, M.R., Gajic, O., Hubmayr, R.D., Gropper, M.A., et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 126 (2013), 357.e29–357.e38.
14. Clifford, L., Jia, Q., Subramanian, A., Yadav, H., Schroeder, D.R., Kor, D.J., Risk factors and clinical outcomes associated with perioperative transfusion-associated circulatory overload. Anesthesiology 126 (2017), 409–418.
15. Marshall, A.L., Levine, M., Howell, M.L., Chang, Y., Riklin, E., Parry, B.A., et al. Dose-associated pulmonary complication rates after fresh frozen plasma administration for warfarin reversal. J Thromb Haemost 14 (2016), 324–330.
16. Piccin, A., Cronin, M., Brady, R., Sweeney, J., Marcheselli, L., Lawlor, E., Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010. Transfusion 55 (2015), 1223–1230.
17. Lieberman, L., Maskens, C., Cserti-Gazdewich, C., Hansen, M., Lin, Y., Pendergrast, J., et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev 27 (2013), 206–212.
18. Holst, L.B., Petersen, M.W., Haase, N., Perner, A., Wetterslev, J., Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ, 350, 2015, h1354.
19. Callum, J.L., Waters, J.H., Shaz, B.H., Sloan, S.R., Murphy, M.F., The AABB recommendations for the choosing wisely campaign of the American Board of Internal Medicine. Transfusion 54 (2014), 2344–2352.
20. Nand, N., Gupta, S.P., Gupta, M.S., Hemodynamic evaluation of blood transfusion in chronic severe anemia with special reference to speed of transfusion. Jpn Heart J 26 (1985), 759–765.
21. Ozier, Y., Mouquet, F., Rieux, C., Mertes, P.M., Muller, J.Y., Caldani, C., et al. Transfusion-associated circulatory overload. Transfus Clin Biol 19 (2012), 263–269.
22. Piccin, A., Cronin, M., Brady, R., Sweeney, J., Marcheselli, L., Lawlor, E., et al. Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010. Transfusion 55 (2015), 1223–1230.
23. Rana, R., Fernandez-Perez, E.R., Khan, S.A., Rana, S., Winters, J.L., Lesnick, T.G., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 46 (2016), 1478–1483.
24. Clifford, L., Jia, Q., Yadav, H., Subramanian, A., Wilson, G.A., Murphy, S.P., et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 122 (2015), 21–28.
25. Goldstein, J.N., Refaai, M.A., Milling, T.J. Jr., Lewis, B., Goldberg-Alberts, R., Hug, B.A., et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet 385 (2015), 2077–2087.
26. Andrzejewski, C. Jr., Casey, M.A., Popovsky, M.A., How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion 53 (2013), 3037–3047.